Abbott Laboratories (ABT) Amortization - Intangibles (2012 - 2026)

Abbott Laboratories (ABT) has 15 years of Amortization - Intangibles data on file, last reported at $422.0 million in Q1 2026.

• For the quarter ending Q1 2026, Amortization - Intangibles changed 0.48% year-over-year to $422.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (down 7.78% YoY), and the FY2025 full-year result was $1.7 billion, down 10.44% from the prior year.
• Amortization - Intangibles steadied at $422.0 million in Q1 2026, from $422.0 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $512.0 million in Q1 2022 to a low of $420.0 million in Q1 2025.
• A 5-year average of $468.3 million and a median of $472.0 million in 2024 frame the typical range for Amortization - Intangibles.
• Across the five-year window, Amortization - Intangibles advanced 0.6% in 2022 and dropped 11.02% in 2025, its largest moves.
• Tracing ABT's Amortization - Intangibles over 5 years: stood at $496.0 million in 2022, then declined by 3.02% to $481.0 million in 2023, then fell by 3.33% to $465.0 million in 2024, then fell by 9.25% to $422.0 million in 2025, then changed by 0.0% to $422.0 million in 2026.
• Business Quant data shows ABT's Amortization - Intangibles at $422.0 million in Q1 2026, $422.0 million in Q4 2025, and $420.0 million in Q3 2025.